A Study of Mobile Phone Application Tool for Menopause Symptom Management

Overview

About this study

The purpose of this study is about assessing the utilization of a mobile phone application (app), designed to improve the menopause experience of midlife women experiencing related symptoms and its association with menopause-related health care utilization.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women between the ages of 45 and 55
  • English speaking (app only available in English)
  • Able to provide informed consent
  • Experiencing menopause symptoms, which will be assessed by a Menopause Rating Scale (MRS) survey score of ≥ 5
  • Has an upcoming Mayo Clinic primary care appointment within 3 weeks of the enrollment and the MRS survey.

Exclusion Criteria: 

  • Lack of willingness to engage with app
  • Inability to provide informed consent

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/20/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Stephanie Faubion, M.D., M.B.A.

Open for enrollment

Contact information:

Oluwaseyitan Oloyede

(507) 538-6811

Oloyede.Oluwaseyitan@mayo.edu

More information

Publications

Publications are currently not available